Amplifon (OTCMKTS:AMFPF) Stock Price Up 12.7% – Still a Buy?

Posted by ABMN Staff on Jan 6th, 2026

Amplifon S.p.A. (OTCMKTS:AMFPF – Get Free Report)’s share price traded up 12.7% during mid-day trading on Monday . The stock traded as high as $16.49 and last traded at $16.49. 4,454 shares changed hands during mid-day trading, an increase of 1,899% from the average session volume of 223 shares. The stock had previously closed at $14.63.

Analysts Set New Price Targets

Separately, BNP Paribas began coverage on Amplifon in a research report on Monday, October 20th. They set an “outperform” rating for the company. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy”.

Get Our Latest Research Report on AMFPF

Amplifon Stock Performance

The firm’s fifty day simple moving average is $16.21 and its 200 day simple moving average is $18.32. The company has a market capitalization of $3.72 billion, a price-to-earnings ratio of 29.45 and a beta of 0.44. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.62 and a quick ratio of 0.54.

Amplifon (OTCMKTS:AMFPF – Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.10 EPS for the quarter, meeting the consensus estimate of $0.10. Amplifon had a net margin of 4.74% and a return on equity of 14.28%. The business had revenue of $661.00 million during the quarter, compared to the consensus estimate of $673.24 million.

Amplifon Company Profile

(Get Free Report)

Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.

Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization.